Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Multiple Sclerosis Pathogenesis: Missing Pieces of an Old Puzzle Publisher Pubmed



Rahmanzadeh R1 ; Bruck W3 ; Minagar A4 ; Sahraian MA1, 2
Authors

Source: Reviews in the Neurosciences Published:2019


Abstract

Traditionally, multiple sclerosis (MS) was considered to be a CD4 T cell-mediated CNS autoimmunity, compatible with experimental autoimmune encephalitis model, which can be characterized by focal lesions in the white matter. However, studies of recent decades revealed several missing pieces of MS puzzle and showed that MS pathogenesis is more complex than the traditional view and may include the following: a primary degenerative process (e.g. oligodendroglial pathology), generalized abnormality of normal-appearing brain tissue, pronounced gray matter pathology, involvement of innate immunity, and CD8 T cells and B cells. Here, we review these findings and discuss their implications in MS pathogenesis. © 2019 Walter de Gruyter GmbH, Berlin/Boston.
Related Docs
View other Related Docs
1. B Cells in Multiple Sclerosis Therapy—A Comprehensive Review, Acta Neurologica Scandinavica (2018)
2. Multiple Sclerosis: Clinical Features, Pathophysiology, Diagnosis, and Management, Neuroinflammation (2018)
3. Demyelination With Preferential Mag Loss: A Complex Message From Ms Paraffin Blocks, Journal of the Neurological Sciences (2018)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (7)
Nima Rezaei (3)
Other Related Docs
4. Role of B Cells in the Pathogenesis of Multiple Sclerosis: Mechanisms of Action, Multiple Sclerosis: A Mechanistic View (2016)
5. The Role of the Cerebellum in Multiple Sclerosis, Cerebellum (2015)
6. Differential Frequency of Cd8+ T Cell Subsets in Multiple Sclerosis Patients With Various Clinical Patterns, PLoS ONE (2016)
7. Introduction to the Neuroimmunology of Multiple Sclerosis, Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (2023)
8. Recent Advances in Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Clinical Applications and Challenges, Frontiers in Cell and Developmental Biology (2025)
9. A Comprehensive Review on the Treatment Approaches of Multiple Sclerosis: Currently and in the Future, Inflammation Research (2019)
10. Monoclonal Antibodies in Multiple Sclerosis Treatment, Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (2023)
11. The Molecular Mechanisms of Vitamin a Deficiency in Multiple Sclerosis, Journal of Molecular Neuroscience (2016)
12. Immunomodulatory Characteristics of Mesenchymal Stem Cells and Their Role in the Treatment of Multiple Sclerosis, Cellular Immunology (2015)
13. Immunopathogenesis of Multiple Sclerosis: Molecular and Cellular Mechanisms and New Immunotherapeutic Approaches, Immunopharmacology and Immunotoxicology (2024)
14. Survivin and Autoimmunity; the Ins and Outs, Immunology Letters (2018)
15. Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence, Clinical Drug Investigation (2019)
16. Il-21 and Il-21-Producing T Cells Are Involved in Multiple Sclerosis Severity and Progression, Immunology Letters (2019)
17. Gray Matter Mri Differentiates Neuromyelitis Optica From Multiple Sclerosis Using Random Forest, Neurology (2016)
18. Increased Expression of Mir-301A in Pbmcs of Patients With Relapsing-Remitting Multiple Sclerosis Is Associated With Reduced Nkrf and Pias3 Expression Levels and Disease Activity, Journal of Neuroimmunology (2018)
19. Evaluating the Efficacy and Safety of Zytuxtm (Rituximab, Aryogen Pharmed) in Iranian Multiple Sclerosis Patients: An Observational Study, Multiple Sclerosis and Related Disorders (2019)
20. Consensus Recommendations for Diagnosis and Treatment of Multiple Sclerosis: 2023 Revision of the Menactrims Guidelines, Multiple Sclerosis and Related Disorders (2024)